chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: warmth( at the injection site); itching ( at the injection site); redness( at the injection site); soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warmth( at the injection site)), MYALGIA (soreness), VACCINATION SITE PRURITUS (itching ( at the injection site)) and VACCINATION SITE ERYTHEMA (redness( at the injection site)) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included Adhesive tape allergy (Allergy to adhesive), Arthritis since 2017, Hypertension and Insomnia (Patient is taking Amitriptyline once daily for sleep). Concomitant products included TELMISARTAN for Blood pressure management, AMITRIPTYLINE for Sleepiness.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced MYALGIA (soreness). On 09-Feb-2021, the patient experienced VACCINATION SITE WARMTH (warmth( at the injection site)). 09-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itching ( at the injection site)) and VACCINATION SITE ERYTHEMA (redness( at the injection site)). The patient was treated with HYDROCORTISONE for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (warmth( at the injection site)), MYALGIA (soreness), VACCINATION SITE PRURITUS (itching ( at the injection site)) and VACCINATION SITE ERYTHEMA (redness( at the injection site)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-034939, MOD-2021-034939 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 17-Jun-2021: Follow-up received, added medical history, concomitant medications. Updated patient demographics and event outcome.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Neck pain, Peripheral swelling
Clinical narrative: Neck pain; Right leg swelling; Chills; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Neck pain), PERIPHERAL SWELLING (Right leg swelling) and CHILLS (Chills) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced NECK PAIN (Neck pain), PERIPHERAL SWELLING (Right leg swelling) and CHILLS (Chills). At the time of the report, NECK PAIN (Neck pain), PERIPHERAL SWELLING (Right leg swelling) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication reported   No Treatment information reported   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Follow-up received on 26-APR-2021 contains Non-significant information; Reporter details updated
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm ) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 24-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm ). At the time of the report, PAIN IN EXTREMITY (Pain in arm ) had resolved.            Patient was taking  blood thinner, small dose of cholesterol medication as concomitant medication. No treatment medication were provided. Action taken for Moderna COVID-19 Vaccine was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 11-Jun-2021: Non Significant information- Patient denied to follow-up.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Asthenia, Blood glucose increased, Blood pressure increased, Bradykinesia
Clinical narrative: stomach sick; diarrhea; did not feel right; felt weak; could not move around my herself; sore left arm; blood pressure was elevated; sugar levels were elevated; was shaking so bad, that she had 8 attempts to finally manage to get her sugar levels tested; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore left arm), BLOOD PRESSURE INCREASED (blood pressure was elevated), BLOOD GLUCOSE INCREASED (sugar levels were elevated), TREMOR (was shaking so bad, that she had 8 attempts to finally manage to get her sugar levels tested) and ASTHENIA (felt weak) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure on 06-Feb-2021, Cholesterol on 06-Feb-2021, Insulin on 06-Feb-2021, Diabetic on 06-Feb-2021 and Anxiety on 06-Feb-2021. Concomitant products included CHOLESTEROL and INSULIN INJECTION for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore left arm), BLOOD PRESSURE INCREASED (blood pressure was elevated), BLOOD GLUCOSE INCREASED (sugar levels were elevated) and TREMOR (was shaking so bad, that she had 8 attempts to finally manage to get her sugar levels tested). On 07-Feb-2021, the patient experienced ASTHENIA (felt weak) and BRADYKINESIA (could not move around my herself). On 08-Feb-2021, the patient experienced FEELING ABNORMAL (did not feel right). On 10-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (stomach sick) and DIARRHOEA (diarrhea). At the time of the report, PAIN IN EXTREMITY (sore left arm), BLOOD PRESSURE INCREASED (blood pressure was elevated), BLOOD GLUCOSE INCREASED (sugar levels were elevated), TREMOR (was shaking so bad, that she had 8 attempts to finally manage to get her sugar levels tested), ASTHENIA (felt weak), BRADYKINESIA (could not move around my herself), FEELING ABNORMAL (did not feel right), ABDOMINAL DISCOMFORT (stomach sick) and DIARRHOEA (diarrhea) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information not provided
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Feeling abnormal, Pain in extremity, Tremor
Clinical narrative: stomach sick; diarrhea; did not feel right; felt weak; could not move around my herself; sore left arm; blood pressure was elevated; sugar levels were elevated; was shaking so bad, that she had 8 attempts to finally manage to get her sugar levels tested; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore left arm), BLOOD PRESSURE INCREASED (blood pressure was elevated), BLOOD GLUCOSE INCREASED (sugar levels were elevated), TREMOR (was shaking so bad, that she had 8 attempts to finally manage to get her sugar levels tested) and ASTHENIA (felt weak) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure on 06-Feb-2021, Cholesterol on 06-Feb-2021, Insulin on 06-Feb-2021, Diabetic on 06-Feb-2021 and Anxiety on 06-Feb-2021. Concomitant products included CHOLESTEROL and INSULIN INJECTION for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore left arm), BLOOD PRESSURE INCREASED (blood pressure was elevated), BLOOD GLUCOSE INCREASED (sugar levels were elevated) and TREMOR (was shaking so bad, that she had 8 attempts to finally manage to get her sugar levels tested). On 07-Feb-2021, the patient experienced ASTHENIA (felt weak) and BRADYKINESIA (could not move around my herself). On 08-Feb-2021, the patient experienced FEELING ABNORMAL (did not feel right). On 10-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (stomach sick) and DIARRHOEA (diarrhea). At the time of the report, PAIN IN EXTREMITY (sore left arm), BLOOD PRESSURE INCREASED (blood pressure was elevated), BLOOD GLUCOSE INCREASED (sugar levels were elevated), TREMOR (was shaking so bad, that she had 8 attempts to finally manage to get her sugar levels tested), ASTHENIA (felt weak), BRADYKINESIA (could not move around my herself), FEELING ABNORMAL (did not feel right), ABDOMINAL DISCOMFORT (stomach sick) and DIARRHOEA (diarrhea) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information not provided
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Flushing, Tachycardia
Clinical narrative: red mark on her cheek; face was flush; rapid heartbeat; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red mark on her cheek), FLUSHING (face was flush) and TACHYCARDIA (rapid heartbeat) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced ERYTHEMA (red mark on her cheek), FLUSHING (face was flush) and TACHYCARDIA (rapid heartbeat). At the time of the report, ERYTHEMA (red mark on her cheek), FLUSHING (face was flush) and TACHYCARDIA (rapid heartbeat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient reported that her PEG test was negative and physician wanted her to take antihistaminic medication before the second dose.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue
Clinical narrative: Fatigue; Light headed; Chills; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), DIZZINESS (Light headed) and CHILLS (Chills) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Fatigue), DIZZINESS (Light headed) and CHILLS (Chills). At the time of the report, FATIGUE (Fatigue), DIZZINESS (Light headed) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information not provided. Treatment information not provided
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Headache, Illness, Influenza like illness
Clinical narrative: chills; Headaches; vomiting and vomited after trying to eat; Became "sick as a dog"; Very uncomfortable; flu-like symptoms; Aching; awful congestion; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Became "sick as a dog"), FEELING ABNORMAL (Very uncomfortable), INFLUENZA LIKE ILLNESS (flu-like symptoms), PAIN (Aching) and NASAL CONGESTION (awful congestion) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 25-Feb-2021, the patient experienced ILLNESS (Became "sick as a dog"), FEELING ABNORMAL (Very uncomfortable), INFLUENZA LIKE ILLNESS (flu-like symptoms), PAIN (Aching), NASAL CONGESTION (awful congestion), HEADACHE (Headaches) and VOMITING (vomiting and vomited after trying to eat). On an unknown date, the patient experienced CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) for Chills, at an unspecified dose and frequency. At the time of the report, ILLNESS (Became "sick as a dog"), FEELING ABNORMAL (Very uncomfortable), INFLUENZA LIKE ILLNESS (flu-like symptoms), PAIN (Aching), NASAL CONGESTION (awful congestion), CHILLS (chills), HEADACHE (Headaches) and VOMITING (vomiting and vomited after trying to eat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Pain, Vomiting
Clinical narrative: chills; Headaches; vomiting and vomited after trying to eat; Became "sick as a dog"; Very uncomfortable; flu-like symptoms; Aching; awful congestion; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Became "sick as a dog"), FEELING ABNORMAL (Very uncomfortable), INFLUENZA LIKE ILLNESS (flu-like symptoms), PAIN (Aching) and NASAL CONGESTION (awful congestion) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 25-Feb-2021, the patient experienced ILLNESS (Became "sick as a dog"), FEELING ABNORMAL (Very uncomfortable), INFLUENZA LIKE ILLNESS (flu-like symptoms), PAIN (Aching), NASAL CONGESTION (awful congestion), HEADACHE (Headaches) and VOMITING (vomiting and vomited after trying to eat). On an unknown date, the patient experienced CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) for Chills, at an unspecified dose and frequency. At the time of the report, ILLNESS (Became "sick as a dog"), FEELING ABNORMAL (Very uncomfortable), INFLUENZA LIKE ILLNESS (flu-like symptoms), PAIN (Aching), NASAL CONGESTION (awful congestion), CHILLS (chills), HEADACHE (Headaches) and VOMITING (vomiting and vomited after trying to eat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Redness at injection site; itching at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PRURITUS (itching at injection site) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PRURITUS (itching at injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PRURITUS (itching at injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information not provided. Treatment information not provided
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site mass
Clinical narrative: knot has appeared at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE MASS (knot has appeared at the injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028620A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INJECTION SITE MASS (knot has appeared at the injection site). At the time of the report, INJECTION SITE MASS (knot has appeared at the injection site) had resolved.            Concomitant information not provided. Treatment information not provided   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Follow up received. Event outcome updated. Second dose information picked from initial source document and action taken with suspect product updated accordingly.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash on both arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on both arm) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     The patient's past medical history included Blood pressure on 03-Feb-2021 and Diabetes on 03-Feb-2021. Concurrent medical conditions included Allergy to plants on 03-Feb-2021 and Food allergy on 03-Feb-2021. Concomitant products included PROSTATE MEDICATION, CHROMIC CHLORIDE, CINNAMOMUM SPP., GYMNEMA SYLVESTRE, THIOCTIC ACID (DIABETES), blood pressure medication and ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced RASH (rash on both arm). At the time of the report, RASH (rash on both arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information not provided
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Side effects from COVID-19 Vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side effects from COVID-19 Vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects from COVID-19 Vaccine). At the time of the report, VACCINATION COMPLICATION (Side effects from COVID-19 Vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Pain, Pain in extremity
Clinical narrative: arm hurt; no energy; body aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurt), ASTHENIA (no energy) and PAIN (body aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO Medical History Information was reported.     On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm hurt), ASTHENIA (no energy) and PAIN (body aches). At the time of the report, PAIN IN EXTREMITY (arm hurt), ASTHENIA (no energy) and PAIN (body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 02-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurt), ASTHENIA (no energy) and PAIN (body aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO Medical History Information was reported.     On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm hurt), ASTHENIA (no energy) and PAIN (body aches). At the time of the report, PAIN IN EXTREMITY (arm hurt), ASTHENIA (no energy) and PAIN (body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Discomfort, Ear infection, Lymphadenopathy, Oropharyngeal pain, Rhinorrhoea
Clinical narrative: discomfort in my right ear and under my right collar bone; swollen lymph nodes on side contralateral to injection; Ear infection/10 days after the first vaccine, I started to feel discomfort in my right ear./ This was the opposite side of vaccine injection. Felt like an ear infection.; soar throat; runny nose; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of EAR INFECTION (Ear infection/10 days after the first vaccine, I started to feel discomfort in my right ear./ This was the opposite side of vaccine injection. Felt like an ear infection.), OROPHARYNGEAL PAIN (soar throat), RHINORRHOEA (runny nose), DISCOMFORT (discomfort in my right ear and under my right collar bone) and LYMPHADENOPATHY (swollen lymph nodes on side contralateral to injection) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     NO Medical History Information was reported.  Concomitant products included LISINOPRIL from 05-May-1988 to an unknown date for Blood pressure high.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced EAR INFECTION (Ear infection/10 days after the first vaccine, I started to feel discomfort in my right ear./ This was the opposite side of vaccine injection. Felt like an ear infection.), OROPHARYNGEAL PAIN (soar throat), RHINORRHOEA (runny nose) and LYMPHADENOPATHY (swollen lymph nodes on side contralateral to injection). On an unknown date, the patient experienced DISCOMFORT (discomfort in my right ear and under my right collar bone). The patient was treated with IBUPROFEN from 22-Feb-2021 to 27-Feb-2021 for Adverse event, at a dose of 200 mg as required and AMOXICILLIN ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, EAR INFECTION (Ear infection/10 days after the first vaccine, I started to feel discomfort in my right ear./ This was the opposite side of vaccine injection. Felt like an ear infection.), OROPHARYNGEAL PAIN (soar throat), RHINORRHOEA (runny nose), DISCOMFORT (discomfort in my right ear and under my right collar bone) and LYMPHADENOPATHY (swollen lymph nodes on side contralateral to injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient went to his Otolaryngologist on 22-Feb-2021 for the reported events.  Doctor advised to take anti inflammatory for any swollen glands or lymph nodes.  Patient tested for wax buildup, inflammation in throat  and speech test all with negative results.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Added patient demographics , Concomitant medication, treatment medication and a new event, discomfort.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) and PYREXIA (Fever) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced CHILLS (chills). On 09-Feb-2021, the patient experienced PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 09-Feb-2021, CHILLS (chills) had resolved. On 10-Feb-2021, PYREXIA (Fever) had resolved.            No concomitant medications were reported.    Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: The follow up document updated on 22-Apr-2021 states patient has taken second dose.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Erythema, Fatigue, Injection site swelling
Clinical narrative: Redness at injection going up towards shoulder joint; Aching all over; Chills; Fever of 100.2; Felt tired; Swelling at injection site; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness at injection going up towards shoulder joint), PAIN (Aching all over), CHILLS (Chills), PYREXIA (Fever of 100.2) and FATIGUE (Felt tired) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Redness at injection going up towards shoulder joint), PAIN (Aching all over), CHILLS (Chills), PYREXIA (Fever of 100.2), FATIGUE (Felt tired) and INJECTION SITE SWELLING (Swelling at injection site). At the time of the report, ERYTHEMA (Redness at injection going up towards shoulder joint), PAIN (Aching all over), CHILLS (Chills), PYREXIA (Fever of 100.2), FATIGUE (Felt tired) and INJECTION SITE SWELLING (Swelling at injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.2 (High) fever of 100.2.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Follow up received and contain non significant information.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Redness at injection going up towards shoulder joint; Aching all over; Chills; Fever of 100.2; Felt tired; Swelling at injection site; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness at injection going up towards shoulder joint), PAIN (Aching all over), CHILLS (Chills), PYREXIA (Fever of 100.2) and FATIGUE (Felt tired) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Redness at injection going up towards shoulder joint), PAIN (Aching all over), CHILLS (Chills), PYREXIA (Fever of 100.2), FATIGUE (Felt tired) and INJECTION SITE SWELLING (Swelling at injection site). At the time of the report, ERYTHEMA (Redness at injection going up towards shoulder joint), PAIN (Aching all over), CHILLS (Chills), PYREXIA (Fever of 100.2), FATIGUE (Felt tired) and INJECTION SITE SWELLING (Swelling at injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.2 (High) fever of 100.2.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Follow up received and contain non significant information.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     NO Medical History Information was reported.     On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Soreness at injection site). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (Soreness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  .   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Non-significant follow up. Another reporter contact details provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 12-Feb-2021 and was forwarded to Moderna on 12-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     NO Medical History Information was reported.     On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Soreness at injection site). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (Soreness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  .   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Non-significant follow up. Another reporter contact details provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: A red area at the site of injection about 4 inches across; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (A red area at the site of injection about 4 inches across) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M204) for COVID-19 vaccination.     No Medical History Information was reported.     On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (A red area at the site of injection about 4 inches across). At the time of the report, VACCINATION SITE ERYTHEMA (A red area at the site of injection about 4 inches across) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 02-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (A red area at the site of injection about 4 inches across) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M204) for COVID-19 vaccination.     No Medical History Information was reported.     On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (A red area at the site of injection about 4 inches across). At the time of the report, VACCINATION SITE ERYTHEMA (A red area at the site of injection about 4 inches across) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Influenza like illness, Malaise, Myalgia
Clinical narrative: became "sick as a dog"; chills; very uncomfortable; flu-like symptoms; awful congestion; headaches; vomiting; aching; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (became "sick as a dog"), VACCINATION COMPLICATION (very uncomfortable), INFLUENZA LIKE ILLNESS (flu-like symptoms), NASAL CONGESTION (awful congestion) and HEADACHE (headaches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced VACCINATION COMPLICATION (very uncomfortable), INFLUENZA LIKE ILLNESS (flu-like symptoms), NASAL CONGESTION (awful congestion), HEADACHE (headaches), VOMITING (vomiting) and MYALGIA (aching). On an unknown date, the patient experienced MALAISE (became "sick as a dog") and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and ACETYLSALICYLIC ACID (ASPIRIN 81) at an unspecified dose and frequency. At the time of the report, MALAISE (became "sick as a dog"), VACCINATION COMPLICATION (very uncomfortable), INFLUENZA LIKE ILLNESS (flu-like symptoms), NASAL CONGESTION (awful congestion), HEADACHE (headaches), VOMITING (vomiting), MYALGIA (aching) and CHILLS (chills) outcome was unknown.      Action taken with mRNA-1273 in response to the events was not applicable      No concomitant medications provided
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Vaccination complication, Vomiting
Clinical narrative: became "sick as a dog"; chills; very uncomfortable; flu-like symptoms; awful congestion; headaches; vomiting; aching; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (became "sick as a dog"), VACCINATION COMPLICATION (very uncomfortable), INFLUENZA LIKE ILLNESS (flu-like symptoms), NASAL CONGESTION (awful congestion) and HEADACHE (headaches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced VACCINATION COMPLICATION (very uncomfortable), INFLUENZA LIKE ILLNESS (flu-like symptoms), NASAL CONGESTION (awful congestion), HEADACHE (headaches), VOMITING (vomiting) and MYALGIA (aching). On an unknown date, the patient experienced MALAISE (became "sick as a dog") and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and ACETYLSALICYLIC ACID (ASPIRIN 81) at an unspecified dose and frequency. At the time of the report, MALAISE (became "sick as a dog"), VACCINATION COMPLICATION (very uncomfortable), INFLUENZA LIKE ILLNESS (flu-like symptoms), NASAL CONGESTION (awful congestion), HEADACHE (headaches), VOMITING (vomiting), MYALGIA (aching) and CHILLS (chills) outcome was unknown.      Action taken with mRNA-1273 in response to the events was not applicable      No concomitant medications provided
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Mobility decreased
Clinical narrative: Joint aches; Could not move; Freezing; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Joint aches), MOBILITY DECREASED (Could not move) and CHILLS (Freezing) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 02-Feb-2021, the patient experienced ARTHRALGIA (Joint aches), MOBILITY DECREASED (Could not move) and CHILLS (Freezing). The patient was treated with PARACETAMOL at an unspecified dose and frequency. At the time of the report, ARTHRALGIA (Joint aches), MOBILITY DECREASED (Could not move) and CHILLS (Freezing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant product use was not provided by the reporter. Lab details were not provided.   This case was linked to MOD-2021-033689 (Patient Link).
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site rash, Injection site reaction, Pain
Clinical narrative: rash around the injection site; body soreness; severe headache; COVID Arm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (rash around the injection site), PAIN (body soreness), HEADACHE (severe headache) and INJECTION SITE REACTION (COVID Arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO Medical History Information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced INJECTION SITE RASH (rash around the injection site), PAIN (body soreness), HEADACHE (severe headache) and INJECTION SITE REACTION (COVID Arm). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, INJECTION SITE RASH (rash around the injection site), PAIN (body soreness), HEADACHE (severe headache) and INJECTION SITE REACTION (COVID Arm) outcome was unknown.            No relevant concomitant medications were reported.    This case was linked to MOD-2021-030502 (Patient Link). This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to the company on 02-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (rash around the injection site), PAIN (body soreness), HEADACHE (severe headache) and INJECTION SITE REACTION (COVID Arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO Medical History Information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced INJECTION SITE RASH (rash around the injection site), PAIN (body soreness), HEADACHE (severe headache) and INJECTION SITE REACTION (COVID Arm). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, INJECTION SITE RASH (rash around the injection site), PAIN (body soreness), HEADACHE (severe headache) and INJECTION SITE REACTION (COVID Arm) outcome was unknown.            No relevant concomitant medications were reported.    This case was linked to MOD-2021-030502 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Head discomfort, Hypersensitivity, Lacrimation increased, Rhinorrhoea, Sneezing
Clinical narrative: allergies bad; running nose; head was stuffy; sneezing; watery eyes; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (allergies bad), RHINORRHOEA (running nose), HEAD DISCOMFORT (head was stuffy), SNEEZING (sneezing) and LACRIMATION INCREASED (watery eyes) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004m20a) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced HYPERSENSITIVITY (allergies bad), RHINORRHOEA (running nose), HEAD DISCOMFORT (head was stuffy), SNEEZING (sneezing) and LACRIMATION INCREASED (watery eyes). At the time of the report, HYPERSENSITIVITY (allergies bad), RHINORRHOEA (running nose), HEAD DISCOMFORT (head was stuffy), SNEEZING (sneezing) and LACRIMATION INCREASED (watery eyes) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), CHILLS (Chills), HEADACHE (Headache) and MYALGIA (Muscle Pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 01-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced PYREXIA (fever), CHILLS (Chills), HEADACHE (Headache) and MYALGIA (Muscle Pain). At the time of the report, PYREXIA (fever), CHILLS (Chills), HEADACHE (Headache) and MYALGIA (Muscle Pain) outcome was unknown. No treatment information was provided. No concomitant medication was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site reaction, Vaccination site swelling
Clinical narrative: developed COVID arm on her left arm.; Itchiness on arm; Redness on arm; Swelling on arm; This spontaneous case was reported by a  and describes the occurrence of VACCINATION SITE REACTION (developed COVID arm on her left arm.), VACCINATION SITE PRURITUS (Itchiness on arm), VACCINATION SITE ERYTHEMA (Redness on arm) and VACCINATION SITE SWELLING (Swelling on arm) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced VACCINATION SITE REACTION (developed COVID arm on her left arm.), VACCINATION SITE PRURITUS (Itchiness on arm), VACCINATION SITE ERYTHEMA (Redness on arm) and VACCINATION SITE SWELLING (Swelling on arm). At the time of the report, VACCINATION SITE REACTION (developed COVID arm on her left arm.), VACCINATION SITE PRURITUS (Itchiness on arm), VACCINATION SITE ERYTHEMA (Redness on arm) and VACCINATION SITE SWELLING (Swelling on arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was reported.   This case was linked to MOD-2021-031866 (Patient Link).
Age: 62.0
Sex: F
Vaccine: COVID19, FLUX
Symptoms: Dizziness, Fatigue, Herpes zoster, Myalgia
Clinical narrative: Shingles; Body aches; Dizziness; Fatigue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (Dizziness), FATIGUE (Fatigue), MYALGIA (Body aches) and HERPES ZOSTER (Shingles) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.    Co-suspect product included non-company product Flu vaccine for an unknown indication.    Concurrent medical conditions included Diabetic and Blood pressure.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started Flu vaccine (unknown route) at an unspecified dose. On 28-Jan-2021, the patient experienced DIZZINESS (Dizziness) and FATIGUE (Fatigue). On 30-Jan-2021, the patient experienced MYALGIA (Body aches). On 22-Feb-2021, the patient experienced HERPES ZOSTER (Shingles). On 31-Jan-2021, DIZZINESS (Dizziness), FATIGUE (Fatigue) and MYALGIA (Body aches) had resolved. At the time of the report, HERPES ZOSTER (Shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Rash
Clinical narrative: Rash back on the  neck; L arm pain; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash back on the  neck) and PAIN IN EXTREMITY (L arm pain) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     Concomitant products included DIHYDRALAZINE SULFATE, HYDROCHLOROTHIAZIDE, RESERPINE, TRIAMTERENE (NO 0) for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced RASH (Rash back on the  neck) and PAIN IN EXTREMITY (L arm pain). At the time of the report, RASH (Rash back on the  neck) and PAIN IN EXTREMITY (L arm pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.